CohBar (CWBR) Competitors $0.41 0.00 (0.00%) As of 01/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsTrends CWBR vs. SONN, ALLR, SNPX, PRTG, BNOX, BPTH, TNFA, OGEN, ATXI, and CELZShould you be buying CohBar stock or one of its competitors? The main competitors of CohBar include Sonnet BioTherapeutics (SONN), Allarity Therapeutics (ALLR), Synaptogenix (SNPX), Portage Biotech (PRTG), Bionomics (BNOX), Bio-Path (BPTH), TNF Pharmaceuticals (TNFA), Oragenics (OGEN), Avenue Therapeutics (ATXI), and Creative Medical Technology (CELZ). These companies are all part of the "pharmaceutical products" industry. CohBar vs. Sonnet BioTherapeutics Allarity Therapeutics Synaptogenix Portage Biotech Bionomics Bio-Path TNF Pharmaceuticals Oragenics Avenue Therapeutics Creative Medical Technology CohBar (NASDAQ:CWBR) and Sonnet BioTherapeutics (NASDAQ:SONN) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, community ranking, profitability, media sentiment and institutional ownership. Do analysts recommend CWBR or SONN? Sonnet BioTherapeutics has a consensus price target of $20.00, suggesting a potential upside of 1,198.70%. Given Sonnet BioTherapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Sonnet BioTherapeutics is more favorable than CohBar.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CohBar 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Sonnet BioTherapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of CWBR or SONN? 2.5% of CohBar shares are owned by institutional investors. Comparatively, 9.4% of Sonnet BioTherapeutics shares are owned by institutional investors. 6.5% of CohBar shares are owned by company insiders. Comparatively, 2.0% of Sonnet BioTherapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has more volatility & risk, CWBR or SONN? CohBar has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, Sonnet BioTherapeutics has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Is CWBR or SONN more profitable? CohBar's return on equity of 0.00% beat Sonnet BioTherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CohBarN/A N/A N/A Sonnet BioTherapeutics N/A -383.45%-150.13% Does the media favor CWBR or SONN? In the previous week, Sonnet BioTherapeutics had 3 more articles in the media than CohBar. MarketBeat recorded 3 mentions for Sonnet BioTherapeutics and 0 mentions for CohBar. CohBar's average media sentiment score of 0.00 equaled Sonnet BioTherapeutics'average media sentiment score. Company Overall Sentiment CohBar Neutral Sonnet BioTherapeutics Neutral Which has stronger earnings & valuation, CWBR or SONN? Sonnet BioTherapeutics has higher revenue and earnings than CohBar. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCohBarN/AN/A-$12.18MN/AN/ASonnet BioTherapeutics$18.63K248.62-$7.44MN/AN/A Does the MarketBeat Community prefer CWBR or SONN? Sonnet BioTherapeutics received 2 more outperform votes than CohBar when rated by MarketBeat users. Likewise, 83.33% of users gave Sonnet BioTherapeutics an outperform vote while only 72.00% of users gave CohBar an outperform vote. CompanyUnderperformOutperformCohBarOutperform Votes1872.00% Underperform Votes728.00% Sonnet BioTherapeuticsOutperform Votes2083.33% Underperform Votes416.67% SummarySonnet BioTherapeutics beats CohBar on 9 of the 13 factors compared between the two stocks. Get CohBar News Delivered to You Automatically Sign up to receive the latest news and ratings for CWBR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CWBR vs. The Competition Export to ExcelMetricCohBarPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.19M$6.57B$5.39B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E RatioN/A10.0188.8317.53Price / SalesN/A315.791,280.48134.21Price / CashN/A22.6336.6032.90Price / Book0.085.084.964.69Net Income-$12.18M$154.90M$117.89M$224.57M7 Day PerformanceN/A1.33%1.67%1.69%1 Month Performance-24.07%1.52%3.62%5.34%1 Year Performance-45.33%4.60%26.15%21.47% CohBar Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CWBRCohBarN/A$0.41flatN/AN/A$1.19MN/A0.0010SONNSonnet BioTherapeutics3.0114 of 5 stars$1.58flat$20.00+1,165.8%+15.8%$4.75M$18,626.000.0010News CoveragePositive NewsALLRAllarity Therapeutics0.6385 of 5 stars$1.07+2.9%N/A-99.6%$4.74MN/A0.0010Positive NewsSNPXSynaptogenix2.0825 of 5 stars$3.34+6.7%$14.00+319.2%-44.5%$4.53MN/A0.004Gap DownPRTGPortage Biotech0.0756 of 5 stars$4.27-2.3%N/A-80.6%$4.48MN/A-0.106Gap DownBNOXBionomics1.6591 of 5 stars$0.25+4.2%$8.00+3,060.8%-75.9%$4.47M$10,000.000.00N/APositive NewsGap UpHigh Trading VolumeBPTHBio-Path1.4615 of 5 stars$0.93-1.7%$20.00+2,041.1%-89.7%$4.02MN/A0.0010Analyst ForecastNews CoverageTNFATNF PharmaceuticalsN/A$1.45+14.6%N/AN/A$4.00MN/A0.006Positive NewsHigh Trading VolumeOGENOragenicsN/A$0.33-5.2%N/AN/A$3.97M$40,000.00-0.055News CoverageATXIAvenue Therapeutics2.9438 of 5 stars$1.90+4.9%N/A-82.4%$3.90MN/A0.104Positive NewsHigh Trading VolumeCELZCreative Medical TechnologyN/A$2.23+2.8%N/A-44.9%$3.90M$11,000.00-0.595Positive NewsGap Up Related Companies and Tools Related Companies Sonnet BioTherapeutics Alternatives Allarity Therapeutics Alternatives Synaptogenix Alternatives Portage Biotech Alternatives Bionomics Alternatives Bio-Path Alternatives TNF Pharmaceuticals Alternatives Oragenics Alternatives Avenue Therapeutics Alternatives Creative Medical Technology Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CWBR) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CohBar, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CohBar With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
